UC San Diego clinical trial suggests ivabradine may be effective in treating postural orthostatic tachycardia syndrome, a potential COVID-19 long-hauler symptom.
Compared to sociobehavioral studies, biomedical studies typically require more time and visits, tend to be more quantitative, more in-person, and of greater risk
COVID-19 variants spreading across the U.S. are more infectious, cause more serious illness and are more deadly – but wearing a mask and social distancing still protect you, and they are as important as they’ve ever been.
During Heart Failure Awareness Week (Feb. 16-19), nine UC Davis experts will discuss heart failure symptoms, prevention, treatment and more in interactive Facebook Live sessions.
Ignacio Saez, assistant professor in the UC Davis Department of Neurological Surgery has been honored with the Edwin Boldrey Award from the San Francisco Neurological Society for his research.
In an effort to help schools reduce the risk of COVID-19 outbreaks as they resume in-person instruction, UC San Diego and the County of San Diego are testing the Safer at School Early Alert system to detect SARS-CoV-2 at schools and child care centers.
UC Davis Medical Center is proud to be recognized by Blue Shield of California with a Blue Distinction Centers (BDC) for Maternity Care designation, as part of the Blue Distinction Specialty Care program.
